These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8720582)

  • 41. Cardiovascular effects of the 5-HT1A receptor ligand, MDL 73005EF, in conscious spontaneously hypertensive rats.
    Buisson-Defferier S; Van den Buuse M
    Eur J Pharmacol; 1992 Nov; 223(2-3):133-41. PubMed ID: 1362161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Full and partial 5-HT1A receptor agonists disrupt learning and performance in rats.
    Winsauer PJ; Rodriguez FH; Cha AE; Moerschbaecher JM
    J Pharmacol Exp Ther; 1999 Jan; 288(1):335-47. PubMed ID: 9862788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
    Van de Kar LD; Li Q; Cabrera TM; Brownfield MS; Battaglia G
    J Pharmacol Exp Ther; 1998 Jul; 286(1):256-62. PubMed ID: 9655867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gliquidone, an ATP-dependent K+ channel antagonist, antagonizes morphine-induced hypermotility.
    Ocaña M; Del Pozo E; Baeyens JM
    Eur J Pharmacol; 1993 Aug; 239(1-3):253-5. PubMed ID: 8223904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
    Misane I; Johansson C; Ogren SO
    Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors.
    Luscombe GP; Martin KF; Hutchins LJ; Gosden J; Heal DJ
    Br J Pharmacol; 1993 Mar; 108(3):669-77. PubMed ID: 8467355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. D2-like receptors mediate the expulsion phase of ejaculation elicited by 8-hydroxy-2-(di-N-propylamino)tetralin in rats.
    Clément P; Bernabé J; Kia HK; Alexandre L; Giuliano F
    J Pharmacol Exp Ther; 2006 Feb; 316(2):830-4. PubMed ID: 16221741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P
    Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
    Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
    J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
    Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
    Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse.
    Dursun SM; Handley SL
    Br J Pharmacol; 1993 Aug; 109(4):1046-52. PubMed ID: 8104640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of MP-3022 on the 8-OH-DPAT-induced discriminative stimulus in rats.
    Filip M; Przegaliński E
    Pol J Pharmacol; 1996; 48(4):397-402. PubMed ID: 9112679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Agonist-dependent modulation of G-protein coupling and transduction of 5-HT1A receptors in rat dorsal raphe nucleus.
    Valdizán EM; Castro E; Pazos A
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):835-43. PubMed ID: 19895724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/G(o) proteins in dorsal raphe nucleus.
    Romero L; Celada P; Artigas F
    Eur J Pharmacol; 1994 Nov; 265(1-2):103-6. PubMed ID: 7883021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
    Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
    Vicentic A; Li Q; Battaglia G; Van de Kar LD
    Eur J Pharmacol; 1998 Apr; 346(2-3):261-6. PubMed ID: 9652368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.